Hospital News and Research

RSS

Biosante Pharmaceuticals, Cell Genesys successfully complete merger

BioSante Pharmaceuticals, Inc. and Cell Genesys, Inc., today announced the successful completion of their previously announced merger of Cell Genesys with and into BioSante, with BioSante as the surviving company, under which BioSante now has acquired all of the outstanding shares of Cell Genesys common stock.

15 Oct 2009

Dramatic effects on Norway's health service

If we continue to use our hospitals in the same way as we do now, the health service in 2030 will need to employ every second young person in the country and increase hospital bed capacity by 5000.

15 Oct 2009

HealthPartners to establish new clinic in Minnesota

HealthPartners today announced that it will open a new 5,000 square foot clinic at 7500 80th Street south in Cottage Grove, Minn. in early 2010.

15 Oct 2009

Less expensive anti-rejection drug as effective as more expensive drug, says study

A newer, less expensive drug used to suppress the immune system and prevent organ rejection in kidney and pancreas transplant patients works just as well as its much more expensive counterpart, according to a new study by researchers at Wake Forest University Baptist Medical Center.

15 Oct 2009

ValenTx to present its first clinical study for the treatment of morbid obesity

ValenTx, Inc. announces the presentation of the first clinical study of their endoluminal approach for the treatment of morbid obesity at the 2009 American College of Surgeons Clinical Congress.

15 Oct 2009

Error in CT scan machine led to radiation overdoses in LA hospital

More than 200 CT scans delivered eight times the normal dose of radiation to potential stroke patients in a Los Angeles area hospital since February 2008 because of a scanner reset, The Los Angeles Times reports.

15 Oct 2009

Blocking folic acid action during early pregnancy leads to increased risk of abnormalities in growing baby

Using medication that reduces or blocks the actions of folic acid during the first trimester of pregnancy (weeks 1-12), increases the risk that the growing baby will develop abnormalities. This conclusion was reached by a team of Epidemiologists, Paediatricians, Clinical Pharmacologists, Obstetricians and Gynaecologists who examined birth and abortion data collected in Israel between 1998 and 2007.

15 Oct 2009

Medications to reduce folic acid during pregnancy increase the risk of abnormalities in fetus

Pregnant women are advised to take vitamin supplements containing folic acid as part of their routine pre-natal care. Now, a new study warns that taking medications that reduce or block the actions of folic acid during the first trimester of pregnancy increase the risk that the growing baby will develop abnormalities.

14 Oct 2009

Solos Endoscopy to obtain the CE Mark for its MammoView line of surgical endoscopy instruments

Solos Endoscopy, Inc. is pleased to announce that the Company has taken the initial steps to obtain the CE Mark for its Food and Drug Administration (FDA) approved MammoView(TM) line of surgical endoscopy instruments. This will allow the MammoView(TM) line to be sold throughout the European Economic Union (EEU).

14 Oct 2009

ACS to develop and maintain the Kentucky Health Information Exchange

Affiliated Computer Services, Inc., today announced that it has been awarded a contract that will help improve the quality of healthcare in Kentucky by providing physicians with a more complete picture of a patient’s medical history.

14 Oct 2009

Riga Eastern Clinical University Hospital commences treatment with the Novalis Tx radiosurgery platform

Doctors in Latvia have begun treatments using the region's first Novalis Tx(TM) radiosurgery platform from Varian Medical Systems and BrainLAB. Two prostate cancer patients have been treated using Varian's RapidArc® radiotherapy technology at the Riga Eastern Clinical University Hospital.

14 Oct 2009

World's first plastic surgery iPhone Application launched

Manhattan-based aesthetic plastic surgeon, Dr. David Shafer, announces The Shafer Plastic Surgery App, the world's first plastic surgery iPhone Application.

14 Oct 2009

Aspenbio Pharma closes public offering of its common stock shares

AspenBio Pharma, Inc. today announced the closing of its previously announced public offering of 5,155,000 shares of its common stock at $1.70 per share. The aggregate number of shares of common stock sold reflects the exercise in full by the underwriter of its over-allotment option to purchase 672,391 additional shares of common stock.

14 Oct 2009

American College of Physician Executives offers new course for physicians to improve patient safety

When systems fail in the health care world, the results can be deadly. So creating the most reliable, safest system possible is always a priority. Now the American College of Physician Executives is offering a new course aimed directly at improving patient safety by helping physicians apply best practices from highly reliable organizations.

14 Oct 2009

Provectus Pharmaceuticals commences compassionate use program of PV-10 for cancer

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, has expanded its compassionate use program for PV-10, making the agent, which is being developed as a therapeutic agent for a broad spectrum of cancers, available for select cancer patients in the United States. The program is already in progress in Australia, where it was initiated in June 2009.

14 Oct 2009

Women with breast cancer can improve their mental health through Transcendental Meditation technique

Women with breast cancer reduced stress and improved their mental health and emotional well being through the Transcendental Meditation technique, according to a new study published in the current issue of the peer-reviewed Integrative Cancer Therapies (Vol. 8, No. 3: September 2009).

14 Oct 2009

Research scientists develop bioengineered treatment for targeting pancreatic cancer

Research scientists from Massachusetts General Hospital, Boston, have developed a novel bioengineered treatment that has shown promise in targeting pancreatic cancer without causing damage to healthy noncancer cells, a typical problem of chemotherapy.

14 Oct 2009

University of North Carolina awarded grant to continue research on rare disease-causing gene mutations

The University of North Carolina at Chapel Hill has been awarded a five-year, $6.2 million renewal grant to continue its work as part of the National Institutes of Health's Rare Diseases Clinical Research Network (RDCRN).

14 Oct 2009

OSUCCC-James and Global Vision Technologies collaborate to deliver a web-based patient registry solution

The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James) has entered into a contract with Global Vision Technologies (GVT) to create and deliver a new, web-based Photo Dynamic Therapy patient registry solution -- ClinicalPURSUIT -- to help streamline the data collection and outcomes analysis process.

14 Oct 2009

Institute of Medicine elects researcher from The Children's Hospital of Philadelphia as its member

A prominent scientist at The Children's Hospital of Philadelphia, Thomas Curran, Ph.D., FRS, has been elected to the Institute of Medicine. Dr. Curran has long been a leading researcher in pediatric oncology.

14 Oct 2009

Hospital News and Research

Biosante Pharmaceuticals, Cell Genesys successfully complete merger

Dramatic effects on Norway's health service

HealthPartners to establish new clinic in Minnesota

Less expensive anti-rejection drug as effective as more expensive drug, says study

ValenTx to present its first clinical study for the treatment of morbid obesity

Error in CT scan machine led to radiation overdoses in LA hospital

Blocking folic acid action during early pregnancy leads to increased risk of abnormalities in growing baby

Medications to reduce folic acid during pregnancy increase the risk of abnormalities in fetus

Solos Endoscopy to obtain the CE Mark for its MammoView line of surgical endoscopy instruments

ACS to develop and maintain the Kentucky Health Information Exchange

Riga Eastern Clinical University Hospital commences treatment with the Novalis Tx radiosurgery platform

World's first plastic surgery iPhone Application launched

Aspenbio Pharma closes public offering of its common stock shares

American College of Physician Executives offers new course for physicians to improve patient safety

Provectus Pharmaceuticals commences compassionate use program of PV-10 for cancer

Women with breast cancer can improve their mental health through Transcendental Meditation technique

Research scientists develop bioengineered treatment for targeting pancreatic cancer

University of North Carolina awarded grant to continue research on rare disease-causing gene mutations

OSUCCC-James and Global Vision Technologies collaborate to deliver a web-based patient registry solution

Institute of Medicine elects researcher from The Children's Hospital of Philadelphia as its member

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News